KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,903,325 | +103.8% | 718,423 | +156.9% | 0.27% | +102.3% |
| Q2 2023 | $11,238,386 | +32.8% | 279,701 | +41.2% | 0.13% | +15.7% |
| Q1 2023 | $8,460,535 | -10.4% | 198,139 | +0.7% | 0.12% | -8.7% |
| Q4 2022 | $9,445,486 | -26.7% | 196,699 | -42.6% | 0.13% | -30.0% |
| Q3 2022 | $12,885,000 | -7.9% | 342,493 | +33.2% | 0.18% | -20.7% |
| Q1 2022 | $13,987,000 | +213.7% | 257,200 | +237.5% | 0.23% | +254.7% |
| Q4 2021 | $4,459,000 | -40.0% | 76,212 | -59.4% | 0.06% | -47.1% |
| Q3 2021 | $7,431,000 | – | 187,835 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |